John Trowsdale Selected Research

HLA-C Antigens (HLA-C)

2/2021	Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity.
1/2015	A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia.
12/2008	NK receptor interactions with MHC class I molecules in pregnancy.
3/2007	A second major histocompatibility complex susceptibility locus for multiple sclerosis.
2/2006	HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis.
10/2004	Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.
9/2002	Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Trowsdale Research Topics

Disease

12	Infections 02/2021 - 03/2002
8	Neoplasms (Cancer) 01/2017 - 09/2003
6	Virus Diseases (Viral Diseases) 02/2021 - 03/2002
4	Autoimmune Diseases (Autoimmune Disease) 10/2015 - 06/2004
3	Pre-Eclampsia (Preeclampsia) 01/2015 - 10/2004
3	Multiple Sclerosis 09/2007 - 01/2006
2	Malaria 02/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 03/2016 - 01/2012
2	Sclerosing Cholangitis 04/2014 - 06/2011
2	Arthritis (Polyarthritis) 09/2011 - 02/2004
2	Colorectal Neoplasms (Colorectal Cancer) 09/2010 - 11/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2007 - 06/2002
2	Psoriatic Arthritis 10/2004 - 09/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Communicable Diseases (Infectious Diseases) 02/2021
1	Disease Susceptibility (Diathesis) 01/2018
1	Necrosis 03/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2014
1	Hypoxia (Hypoxemia) 08/2012
1	Vascular Remodeling 08/2012
1	Rheumatoid Arthritis 09/2011
1	HIV Infections (HIV Infection) 03/2011
1	Critical Illness (Critically Ill) 02/2011
1	Sepsis (Septicemia) 02/2011
1	Ovarian Neoplasms (Ovarian Cancer) 09/2010
1	Carcinogenesis 11/2009
1	Neoplasm Metastasis (Metastasis) 11/2009
1	Carcinoma (Carcinomatosis) 11/2009
1	Salmonella Infections (Salmonellosis) 08/2009
1	Celiac Disease (Celiac Sprue) 01/2009
1	Familial Mediterranean Fever (Periodic Disease) 04/2007
1	Sjogren's Syndrome (Sjogren Syndrome) 03/2007
1	Shock 03/2006
1	Bronchiectasis 02/2006
1	Sarcoidosis (Schaumann Disease) 01/2006
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2005
1	Leukemia 07/2005

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 02/2021 - 08/2002
7	HLA-C Antigens (HLA-C)IBA 02/2021 - 09/2002
5	Proteins (Proteins, Gene)FDA Link 11/2009 - 06/2002
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 01/2006
4	KIR ReceptorsIBA 01/2020 - 02/2006
4	Peptides (Polypeptides)IBA 01/2017 - 09/2004
3	AntibodiesIBA 01/2012 - 03/2007
2	CytokinesIBA 01/2020 - 08/2002
2	Immunoglobulins (Immunoglobulin)IBA 04/2014 - 10/2004
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 09/2007 - 03/2002
2	AutoantigensIBA 09/2007 - 06/2002
2	AutoantibodiesIBA 04/2007 - 06/2002
2	HLA-DRB1 Chains (HLA DRB1)IBA 03/2007 - 01/2006
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	AntigensIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Keratin-8 (Keratin 8)IBA 03/2016
1	EpitopesIBA 01/2015
1	Leukocyte Immunoglobulin-like Receptor B1IBA 03/2014
1	invariant chain (Ii-Key)IBA 04/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2012
1	InterferonsIBA 08/2012
1	MonocrotalineIBA 08/2012
1	2,4-bis(2-acetoxybenzamido)benzoic acid (AB 50)IBA 01/2012
1	Formaldehyde (Formol)FDA Link 01/2012
1	ParaffinIBA 01/2012
1	NK Cell Lectin-Like Receptor Subfamily KIBA 09/2011
1	Collagen Type II (Type II Collagen)IBA 09/2011
1	HLA-B*27:05 antigenIBA 03/2011
1	GABA-A Receptors (GABA(A) Receptor)IBA 02/2011
1	BenzodiazepinesIBA 02/2011
1	Diazepam (Valium)FDA LinkGeneric 02/2011
1	SolutionsIBA 02/2011
1	Thiopental (Pentothal)FDA Link 02/2011
1	Propofol (Diprivan)FDA LinkGeneric 02/2011
1	HLA-DR Antigens (HLA-DR)IBA 08/2009
1	micaIBA 01/2009
1	Mannose (D-Mannose)IBA 09/2007
1	A-factor (Streptomyces)IBA 09/2007
1	Myelin-Oligodendrocyte GlycoproteinIBA 09/2007
1	PyrinIBA 04/2007
1	Alanine (L-Alanine)FDA Link 04/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2007
1	Bacterial Proteins (Bacterial Protein)IBA 04/2007
1	Immunoglobulin G (IgG)IBA 04/2007
1	SuperantigensIBA 04/2007
1	Messenger RNA (mRNA)IBA 08/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2006
1	Transcription Factors (Transcription Factor)IBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 02/2006
1	P-2 (P 2)IBA 01/2006
1	Prostaglandins FIBA 06/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2004
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 02/2004
1	tapasinIBA 09/2003
1	Histocompatibility Antigens Class IIBA 09/2003
1	KIR2DL1 ReceptorsIBA 09/2002

Therapy/Procedure

2	Hematopoietic Stem Cell Transplantation 01/2022 - 07/2005
2	Immunotherapy 01/2017 - 08/2016
2	Transplantation 01/2017 - 08/2016
1	Therapeutics 01/2022
1	Liver Transplantation 04/2014
1	Critical Care (Surgical Intensive Care) 02/2011